Advertisement

Topics

Ancora Heart Inc. Company Profile

06:56 EST 12th December 2018 | BioPortfolio

Ancora Heart, Inc., based in Santa Clara, Calif., is dedicated to helping people with heart failure feel better and live longer. Ancora Heart developed the AccuCinch System, an investigational therapy designed to repair the enlarged left ventricle targeting the underlying cause of heart failure. The AccuCinch heart failure treatment was created to benefit the millions of patients who otherwise have no minimally invasive option available to them. For more information visit www.ancoraheart.com.


News Articles [1362 Associated News Articles listed on BioPortfolio]

Ancora Heart raises $17.8m funding for heart failure therapy

US-based Ancora Heart has raised $17.8m financingto support continued clinical assessment of its AccuCinch ventricular repair system.

Funding round pulls in $17.8M for Ancora Heart

A round of financing brought in $17.8 million for Santa Clara, Calif.-based Ancora Heart, bringing the company closer to its  -More- 

Ancora Heart unveils encouraging initial safety data from heart failure therapy study

Ancora Heart presented the data at the 30th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation. The company claims that the tran...

Ancora Heart gets $17.8mm in first tranche of late-stage financing

Cardiovascular device maker Ancora Heart Inc. raised $17.8mm in an initial tranche of a late-stage financing that could bring in $30mm. Savitr Capital led and was joined by other returning backers. Ac...

Ancora Heart announces positive data of study evaluating AccuCinch Ventricular Repair System

Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced positive clinical data from the company's recently expanded U.S. early feasibility study evaluating t...

Ancora Heart Announces Key Activities for Transcatheter Cardiovascular Therapeutics 2018

Interim Data Will Be Presented from Safety Study of First-of-Its-Kind Heart Failure Therapy Ancora Heart, Inc., a company developing a novel therapy to address heart fa...

Le azioni Aurora Cannabis: chi ha adesso ancora dei dubbi?

Le azioni di Aurora Cannabis martedì hanno fatto ancora un altro grande balzo verso gli abissi. Nel mercato tedesco si è avuto subito un ribasso pari a oltre il 5 %. Quindi la discesa prosegue, e q....

Ancora Heart Announces Positive Interim Analysis from Study of First-of-Its-Kind Heart Failure Therapy

Encouraging Initial Safety and Compelling Early Efficacy Data Presented at TCT 2018 Ancora Heart, Inc., a company developing a novel therapy to address heart failure, t...

PubMed Articles [1999 Associated PubMed Articles listed on BioPortfolio]

Common Postoperative Heart Transplant Complications.

Heart failure or congestive heart failure remains a major public health concern on the global scale. End-stage heart failure is a severe disease where the heart is unable to pump enough oxygen and nut...

Determinants of Heart Rate Variability in the General Population: The Lifelines Cohort Study Determinants of Heart Rate Variability.

Heart rate variability (HRV) is an important marker of heart health with low values reflecting reduced vagal control of the heart rhythm.

The potential multiple effects of beta3-adrenergic receptor agonists on the heart protection for patients with heart failure with preserved ejection fraction.

Children with Heart Conditions and Their Special Health Care Needs - United States, 2016.

Children with heart conditions often use more health care services and specialized care than children without a heart condition (1); however, little is known about the number of U.S. children with hea...

Heart rate control or tailored heart rate to improve ventriculo-arterial coupling in heart failure?

Clinical Trials [4080 Associated Clinical Trials listed on BioPortfolio]

Curing Atrial Fibrillation in Heart Failure

Heart failure is a condition that occurs when the heart muscle weakens and no longer contracts normally. Half of these patients have an irregularity of heart rhythm called atrial fibrilla...

A Partnership to Translate an Evidence-based Intervention (Take Heart) for Vulnerable Older Adults With Heart Disease

To evaluate the effectiveness of Take Heart, a behavioral/educational program for adults age 50+ with heart disease, or with at least two risk factors for heart disease, that helps them to...

“ALOFT – Aliskiren Observation of Heart Failure Treatment”: Efficacy and Safety of Aliskiren Added on Top of Standard Therapy in Adults (≥ 18 Years) With Stable Heart Failure

This study was designed to determine if patients, who have both high blood pressure and heart failure and are currently receiving drug treatment for heart failure, have an improvement in t...

Heart Failure in Adult Patients With a History of Congenital Heart Disease

In today's world of advanced surgery, children born with congenital heart disease (CHD) are surviving into adulthood. However, the surgical procedures these children undergo do not cure th...

Attain Model 4196 Left Ventricular (LV) Lead

Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. When there are ch...

Companies [709 Associated Companies listed on BioPortfolio]

Ancora Heart Inc.

Ancora Heart, Inc., based in Santa Clara, Calif., is dedicated to helping people with heart failure feel better and live longer. Ancora Heart developed the AccuCinch System, an in...

Ancora Heart, Inc.

Ancora Heart, Inc., based in Santa Clara, Calif., is dedicated to helping people with heart failure feel better and live longer. Ancora Heart developed the AccuCinch System, an in...

Ancora Pharmaceuticals Inc.

Ancora’s cutting edge technology enables the rapid, milligram to kilogram production of synthetic carbohydrates for use in drug discovery and industrial applications.

IPS HEART

IPS HEART is a privately-held biopharmaceutical company dedicated to addressing heart attack, heart failure and duchenne cardiomyopathy via next generation cellular therapy. IPS H...

Sunshine Heart

Heart failure is a common condition in which the heart becomes unable to pump sufficient blood to meet the body's needs. Over five million people in the United States have heart failure and it results...

More Information about "Ancora Heart Inc." on BioPortfolio

We have published hundreds of Ancora Heart Inc. news stories on BioPortfolio along with dozens of Ancora Heart Inc. Clinical Trials and PubMed Articles about Ancora Heart Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ancora Heart Inc. Companies in our database. You can also find out about relevant Ancora Heart Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...


Corporate Database Quicklinks



Searches Linking to this Company Record